Yuri Shoshan

Yuri Shoshan has extensive work experience in various leadership roles. Yuri is currently the Chief Executive Officer at Augmanity Nano since 2017. In 2020, they also took on the role of Chief Operating Officer at 1E Therapeutics and became a Board Member at Aummune. Prior to these positions, Yuri served as the Chief Executive Officer and Chief Operating Officer at ReSec Technologies, developing innovative security solutions. Yuri also worked as an Operating Partner at PICO Venture Partners, where they provided management support to portfolio companies. Earlier in their career, Yuri was the CEO of Qualitas Health, leading a team in the development of high-value health products. Yuri has also held CEO positions at Motorika Ltd. and The Medinvest Group, managing medical device companies. Additionally, Yuri served as the CFO of BiolineRx, a publicly traded drug development company, and worked as a Principal at Pitango Venture Capital.

Yuri Shoshan completed their Bachelor's degree in Economics and Mathematics at Columbia University from 1987 to 1991. Following that, they pursued an MBA in General Management from Harvard Business School, where they studied from 1994 to 1996. Prior to these higher education experiences, there is no information provided about Yuri Shoshan's educational background.